Diabetic Gastroparesis Clinical Trials

A clinical trial is being conducted to assess the safety and efficacy of a treatment for patients with diabetic and non-diabetic gastroparesis.  

Diabetic Gastroparesis creates feelings of bloating, nausea, vomiting and pain.

0099 : A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gastroparesis.

METO-IN-004 : A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men with symptoms associated with Diabetic Gastroparesis.

METO-IN-003 : A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women with symptoms associated with Diabetic Gastroparesis.

A phase 2, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of RM -131 administered to patients with diabetic gastroparesis

Nausea, vomiting or feeling full quickly after eating? If you have gastroparesis and you experience nausea, vomiting or belly pain after meals, sitting down to a meal might not always be a joyful experience. This means you may need a different approach to your gastroparesis treatment.  If you have diagnosed ...

A research study is evaluating an investigational drug that may help improve the quality of life for adults with gastroparesis by easing symptoms.  

At the start of the treatment period, participants will randomly (by chance) receive either: -  The investigational study medication, at one of three doses (a 75% chance)-  A placebo (a 25% chance)  

Diabetic gastroparesis creates feelings of bloating, nausea, vomiting and pain. If you have diabetes, ClinSearch is enrolling volunteers in a study testing an investigational medication.